TEMPORARY REMOVAL: IgM anti-malondialdehyde low density lipoprotein antibody levels indicate coronary heart disease and necrotic core characteristics in the Nordic Diltiazem (NORDIL) study and the Integrated Imaging and Biomarker Study 3 (IBIS-3)

Victor J. van den Berg; Dorian O. Haskard; Artur Fedorowski; Adam Hartley; Isabella Kardys; Mikhail Caga-Anan; K. Martijn Akkerhuis; Rohit M. Oemrawsingh; Robert Jan van Geuns; Peter de Jaegere; Nicolas van Mieghem; Evelyn Regar; Jurgen M.R. Ligthart; Victor A.W.M. Umans; Patrick W. Serruys; Olle Melander; Eric Boersma; Ramzi Y. Khamis

doi:10.1016/j.ebiom.2018.08.023

TEMPORARY REMOVAL: IgM anti-malondialdehyde low density lipoprotein antibody levels indicate coronary heart disease and necrotic core characteristics in the Nordic Diltiazem (NORDIL) study and the Integrated Imaging and Biomarker Study 3 (IBIS-3)

Victor J. van den Berg, Dorian O. Haskard, Artur Fedorowski, Adam Hartley, Isabella Kardys, Mikhail Caga-Anan, K. Martijn Akkerhuis, Rohit M. Oemrawsingh, Robert Jan van Geuns, Peter de Jaegere, Nicolas van Mieghem, Evelyn Regar, Jurgen M.R. Ligthart, Victor A.W.M. Umans, Patrick W. Serruys, Olle Melander, Eric Boersma, Ramzi Y. Khamis

Research output: Contribution to a Journal (Peer & Non Peer) › Article › peer-review

30 Citations (Scopus)

Original language	English
Pages (from-to)	63-72
Number of pages	10
Journal	eBioMedicine
Volume	36
DOIs	https://doi.org/10.1016/j.ebiom.2018.08.023
Publication status	Published - Oct 2018
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ebiom.2018.08.023

Cite this

van den Berg, V. J., Haskard, D. O., Fedorowski, A., Hartley, A., Kardys, I., Caga-Anan, M., Martijn Akkerhuis, K., Oemrawsingh, R. M., van Geuns, R. J., de Jaegere, P., van Mieghem, N., Regar, E., Ligthart, J. M. R., Umans, V. A. W. M., Serruys, P. W., Melander, O., Boersma, E., & Khamis, R. Y. (2018). TEMPORARY REMOVAL: IgM anti-malondialdehyde low density lipoprotein antibody levels indicate coronary heart disease and necrotic core characteristics in the Nordic Diltiazem (NORDIL) study and the Integrated Imaging and Biomarker Study 3 (IBIS-3). eBioMedicine, 36, 63-72. https://doi.org/10.1016/j.ebiom.2018.08.023

@article{5d64e128d59c427cb704c26ffdfda050,

title = "TEMPORARY REMOVAL: IgM anti-malondialdehyde low density lipoprotein antibody levels indicate coronary heart disease and necrotic core characteristics in the Nordic Diltiazem (NORDIL) study and the Integrated Imaging and Biomarker Study 3 (IBIS-3)",

author = "\{van den Berg\}, \{Victor J.\} and Haskard, \{Dorian O.\} and Artur Fedorowski and Adam Hartley and Isabella Kardys and Mikhail Caga-Anan and \{Martijn Akkerhuis\}, K. and Oemrawsingh, \{Rohit M.\} and \{van Geuns\}, \{Robert Jan\} and \{de Jaegere\}, Peter and \{van Mieghem\}, Nicolas and Evelyn Regar and Ligthart, \{Jurgen M.R.\} and Umans, \{Victor A.W.M.\} and Serruys, \{Patrick W.\} and Olle Melander and Eric Boersma and Khamis, \{Ramzi Y.\}",

year = "2018",

month = oct,

doi = "10.1016/j.ebiom.2018.08.023",

language = "English",

volume = "36",

pages = "63--72",

journal = "eBioMedicine",

issn = "2352-3964",

publisher = "Elsevier B.V.",

}

van den Berg, VJ, Haskard, DO, Fedorowski, A, Hartley, A, Kardys, I, Caga-Anan, M, Martijn Akkerhuis, K, Oemrawsingh, RM, van Geuns, RJ, de Jaegere, P, van Mieghem, N, Regar, E, Ligthart, JMR, Umans, VAWM, Serruys, PW, Melander, O, Boersma, E & Khamis, RY 2018, 'TEMPORARY REMOVAL: IgM anti-malondialdehyde low density lipoprotein antibody levels indicate coronary heart disease and necrotic core characteristics in the Nordic Diltiazem (NORDIL) study and the Integrated Imaging and Biomarker Study 3 (IBIS-3)', eBioMedicine, vol. 36, pp. 63-72. https://doi.org/10.1016/j.ebiom.2018.08.023

TEMPORARY REMOVAL: IgM anti-malondialdehyde low density lipoprotein antibody levels indicate coronary heart disease and necrotic core characteristics in the Nordic Diltiazem (NORDIL) study and the Integrated Imaging and Biomarker Study 3 (IBIS-3). / van den Berg, Victor J.; Haskard, Dorian O.; Fedorowski, Artur et al.
In: eBioMedicine, Vol. 36, 10.2018, p. 63-72.

Research output: Contribution to a Journal (Peer & Non Peer) › Article › peer-review

TY - JOUR

T1 - TEMPORARY REMOVAL

T2 - IgM anti-malondialdehyde low density lipoprotein antibody levels indicate coronary heart disease and necrotic core characteristics in the Nordic Diltiazem (NORDIL) study and the Integrated Imaging and Biomarker Study 3 (IBIS-3)

AU - van den Berg, Victor J.

AU - Haskard, Dorian O.

AU - Fedorowski, Artur

AU - Hartley, Adam

AU - Kardys, Isabella

AU - Caga-Anan, Mikhail

AU - Martijn Akkerhuis, K.

AU - Oemrawsingh, Rohit M.

AU - van Geuns, Robert Jan

AU - de Jaegere, Peter

AU - van Mieghem, Nicolas

AU - Regar, Evelyn

AU - Ligthart, Jurgen M.R.

AU - Umans, Victor A.W.M.

AU - Serruys, Patrick W.

AU - Melander, Olle

AU - Boersma, Eric

AU - Khamis, Ramzi Y.

PY - 2018/10

Y1 - 2018/10

UR - http://www.scopus.com/inward/record.url?scp=85051660036&partnerID=8YFLogxK

U2 - 10.1016/j.ebiom.2018.08.023

DO - 10.1016/j.ebiom.2018.08.023

M3 - Article

C2 - 30131305

AN - SCOPUS:85051660036

SN - 2352-3964

VL - 36

SP - 63

EP - 72

JO - eBioMedicine

JF - eBioMedicine

ER -

van den Berg VJ, Haskard DO, Fedorowski A, Hartley A, Kardys I, Caga-Anan M et al. TEMPORARY REMOVAL: IgM anti-malondialdehyde low density lipoprotein antibody levels indicate coronary heart disease and necrotic core characteristics in the Nordic Diltiazem (NORDIL) study and the Integrated Imaging and Biomarker Study 3 (IBIS-3). eBioMedicine. 2018 Oct;36:63-72. doi: 10.1016/j.ebiom.2018.08.023

TEMPORARY REMOVAL: IgM anti-malondialdehyde low density lipoprotein antibody levels indicate coronary heart disease and necrotic core characteristics in the Nordic Diltiazem (NORDIL) study and the Integrated Imaging and Biomarker Study 3 (IBIS-3)

UN SDGs

Access to Document

Other files and links

Cite this